Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 10, 2012, Pages 1349-1353

  Balcells, María Elvira ^a   Garcia P ^a   Chanqueo, L ^b   Bahamondes, L ^c   Lasso, M ^a,d   Gallardo, A M ^e   Cifuentes, L ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL SAN JUAN DE DIOS   (Chile)

^c Dr Lucio Cordova Hospital of Infectious Diseases   (Chile)

^d HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^e HOSPITAL DEL SALVADOR   (Chile)

Author keywords

Diagnosis; HIV; Tuberculosis; Xpert MTB RIF

Indexed keywords

RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CHILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MOLECULAR DIAGNOSIS; MOUTH HYGIENE; MULTICENTER STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR;

CHILE; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; HIV; HIV INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84866460852     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0156     Document Type: Article

References (29)

1. World Health Organization. Global tuberculosis control 2010. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/ publications/global-report/2010 Accessed June 2012.
2. Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58 (RR-4): 31-36.
3. Monkongdee P, McCarthy K D, Cain K P, et al. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med 2009; 180: 903-908.
4. Reid M J, Shah N S. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009; 9: 173-184.
5. Dawson R, Masuka P, Edwards D J, et al. Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 2010; 14: 52-58.
6. Getahun H, Kittikraisak W, Heilig C M, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-contrained settings: individual participant data metaanalysis of observational studies. PLoS Med 2011; 8: e1000391.
7. World Health Organization. Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva, Switzerland: WHO, 2010. http://www.who.int/hiv/ pub/tb/9789241500708/en/index.html Accessed June 2012.
8. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF MTB/RIF assay. J Clin Microbiol 2010; 48: 2495-2501.
9. Marlowe E M, Novak-Weekley S M, Cumpio J, et al. Evaluation of the Cepheid Xpert MTB/RIF assay for the direct detection of Mycobacterium tuberculosis complex from respiratory specimens. J Clin Microbiol 2011; 49: 1621-1623.
10. Malbruny B, Le Marrec G, Courageux K, et al. Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples. Int J Tuberc Lung Dis 2011; 15: 553-555.
11. Scott L E, McCarthy K, Gous N, et al. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in high HIV prevalence setting: a prospective study. PLoS Med 2011; 8: e1001061.
12. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
13. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multi drug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
14. World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test. Technical and operational 'how-to' practical considerations. Geneva, Switzerland: WHO, 2011.
15. Departamento de Epidemiología, Ministerio de Salud. Tasa de incidencia de tuberculosis en todas sus formas por regiones, Chile: 2000-2009. Santiago, Chile: Ministerio de Salud, 2009. http://epi.minsal.cl/epi/html/ AtlasInteractivos/Nacionales/AtlasTBC/atlas.html Accessed June 2012. [Spanish]
16. Van Rie A, Page-Shipp L, Scott L, et al. Xpert® MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn 2010; 1087: 937-946.
17. Pai M, Ramsay A, O'Brien R. Evidence based tuberculosis diagnosis. PLoS Med 2008; 5: e156. doi:10.1371/journal.pmed.0050156.
18. Center for Diseases Control. Trends in tuberculosis incidence - United States, 2010. MMWR 2011; 60: 333-337.
19. Dimairo M, MacPherson P, Bandason T, et al. The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12-month cohort study in Harare, Zimbabwe. PLoS ONE 2010; 5: e11849.
20. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010; 48: 229-237.
21. Rachow A, Zumla A, Heinrich N, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay - a clinical validation study. PLoS ONE 2011; 6: e20458.
22. Lawn S D, Brooks S V, Kranzer K, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011; 8: e1001067.
23. Mugusi F, Villamor E, Urassa W, et al. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006; 10: 663-669. (Pubitemid 43845028)
24. Wang J Y, Lee L N, Chou C S, et al. Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol 2004; 42: 4599-4603.
25. Villarroel L, Rabagliati R, Balcells M E, et al. [Prevalence of tuberculosis and its impact on mortality among HIV infected patients in Chile]. Rev Med Chile 2008; 136: 575-582. [Spanish]
26. Gandhi N R, Shah N S, Andrews J R, et al. HIV co-infection in multidrug and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010; 181: 80-86.
27. Davis L, Huang L, Kovacs J A, et al. Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis 2009; 48: 725-732.
28. Tostmann A, Kik S V, Kalisvaart N A, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 2008; 47: 1135-1142.
29. Behr M A, Warren S A, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449. (Pubitemid 29067335)